← Open Payments lookup

AUTUMN MEJIA: Open Payments

NPI 1417615303 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,651 in 98 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $550 · 2025 $1,651

Food & beverage: $1,651
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$228
Novo Nordisk Inc14$217
PFIZER INC.15$201
ABBVIE INC.15$201
Lilly USA, LLC11$172
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$97
Boehringer Ingelheim Pharmaceuticals, Inc.5$75
Dexcom, Inc.3$62
Phathom Pharmaceuticals, Inc.3$43
KYOWA KIRIN, INC.2$42

Products named: FARXIGA, MOUNJARO, JARDIANCE, NURTEC ODT, XIFAXAN, QULIPTA, Ozempic, UBRELVY.

Industry payments across VA — which companies pay providers there.